Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000899243-22-036970

Chief Business Officer sold 5,000 shares at $26.03 ($130,150)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Robb Gary Charles Chief Business Officer 2022-11-22 Sale −4,814 $26.03 $125,308 21,329 D: show line 1 in the form
Robb Gary Charles Chief Business Officer 2022-11-23 Sale −186 $26.03 $4,842 21,143 D: show line 2 in the form
Open-market sales · 5,000 sh · avg $26.03 · $130,150
Loading xslF345X03/doc4.xml…